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ABSTRACT
Background: Age-related macular degeneration (AMD) is a leading cause
of blindness in the United States among adults age 60 and older. While
oxidative stress is implicated in the pathogenesis of AMD, dietary antioxidants have been shown to delay AMD progression in clinical studies.
We hypothesized that N-acetylcysteine amide (NACA), a thiol antioxidant,
would protect retinal pigment epithelium and impede progression of retinal
degeneration. Methods: tert-Butyl hydroperoxide (TBHP) was used to induce oxidative stress in cell cultures. The goal was to evaluate the efficacy
of NACA in an in vitro model of AMD in primary human retinal pigment
epithelial cells (HRPEpiC). Results: Our data indicates that TBHP generated reactive oxygen species (ROS), which reduced cell viability, depleted
glutathione (GSH) levels, and compromised glutathione reductase (GR)
activity. Pretreatment with NACA significantly reduced ROS generation,
restored GSH levels and GR activity, and recovered transepithelial electrical
resistance. Pretreatment with NACA did not decrease the number of dying cells as determined by flow cytometry analysis. However, survival was
significantly improved when cells were co-exposed to NACA and TBHP after a shortened pretreatment period. Conclusion: Our data suggest that
pretreatment with NACA reduces sublethal but not lethal effects of TBHP
in HRPEpiC. NACA significantly improves cell survival when administered

prior to and during oxidative damage similar to that observed in the development of dry AMD. These results indicate that continuation of a thiol antioxidant regimen for treatment of AMD is beneficial throughout the course
of the disease, and NACA is a potent antioxidant that should be further
evaluated for this purpose.
Key words: N-acetylcysteine amide, Thiol antioxidant, Oxidative free radical damage, Retinal pigment epithelium.
Key Messages: NACA defends RPE against oxidative stress in an in vitro
model of AMD.
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INTRODUCTION
Age-related macular degeneration (AMD) accounts for 8.7% of blindness worldwide, and it is a leading cause of blindness in the United States
among adults age 60 and older.1-3 Globally, about 1 in 32 visual impairments and 1 in 15 cases of blindness are due to macular disease.4 Dry
AMD is a degenerative condition that begins in Bruch’s membrane and
progresses to the retinal pigment epithelium (RPE) and the overlying
photoreceptors with loss of central vision. The RPE is a single layer of
pigment cells lying between the photoreceptors and choriocapillaris.
The functions of the RPE include light absorption, epithelial transport,
phagocytosis, secretion, and immune modulation. All of these functions
are important to maintaining and supporting the photoreceptors. High
blood flow rate and high O2 saturation in the choriocapillaris render the
RPE more exposed to oxidative stress.5
Oxidative stress seems to play a major role in the pathogenesis of dry
AMD and retinal degeneration, although the pathophysiology of dry
AMD is complex.5,6 The macula is subject to increased levels of photooxidative stress because of its elevated metabolic rate and high proportion of polyunsaturated fatty acids, which are highly susceptible to lipid
peroxidation. As the RPE cells of the macula age, oxidation of lipids and
other cellular components results in an accumulation of indigestible lipofuscin in the lysosomes. The accumulation of lipofuscin granules closely
parallels drusen formation in time course and distribution in the retina.
Oxidative damage to the mitochondrial DNA in RPE cells has also been
implicated in the development of AMD. Levels of antioxidants in retinal
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tissue, in particular glutathione (GSH), decrease with aging, making the
macula even more vulnerable to progressive oxidative damage.7,8
Endogenous antioxidants, such as GSH, cannot be replaced directly. Instead, compounds that can easily enter cells and increase intracellular
antioxidant levels are preferred. Dietary antioxidants have been shown
to slow the progression of retinal degeneration and halt progression of
AMD in human clinical trials.9,10 GSH and its amino acid precursors
protect RPE cells from oxidative injury and oxidant-induced apoptosis
in vitro. N-acetylcysteine amide (NACA), a GSH prodrug, is a promising candidate for use as an antioxidant-based treatment for AMD. It has
demonstrated efficacy in numerous in vitro and animal models of other
oxidative stress-related conditions, including drug-induced RPE damage and cataracts.11-15 Our lab has demonstrated that NACA prevented
retinal degeneration in vitro and in animal models.14 The immortalized
ARPE-19 cell line was used as an in vitro model because primary human
RPE cells were not available at the time. ROS generation and lipid peroxidation induced by tert-butyl hydroperoxide (TBHP) were reversed by
pretreatment with NACA. NACA also protected against TBHP-induced
cell damage by increasing cellular levels of GSH, and maintaining cellular integrity, as measured by transepithelial electrical resistance (TEER).
In an animal model, phototoxicity-induced photoreceptor cell death and
photoreceptor dysfunction were prevented by NACA.14
The experiments reported here utilized primary cultures of human retinal pigment epithelial cells (HRPEpiC), the best available in vitro model
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for studying RPE-related disorders. Because we attempted to mimic a human disease and provide a solution using a “disease-in-the-dish” model,
choosing the most representative cell model was critical. Thus, we decided to determine whether the beneficial effects of NACA observed in
ARPE-19 cells could also be observed in the HRPEpiC. Our goals were
to investigate the following: (1) the sublethal and lethal effects of TBHP
in HRPEpiC and (2) the protective effects of NACA pretreatment against
TBHP-induced oxidative damage. Sublethal effects included changes in
redox status (ROS generation, GSH levels and GR activity) and monolayer integrity (TEER and dextran permeability). Lethal effects were determined with cell viability and apoptosis assays.

MATERIALS AND METHODS
Materials
N-acetylcysteine amide (NACA) was provided by Dr. Glenn Goldstein
(David Pharmaceuticals, New York, NY, USA). Human retinal pigment
epithelial cells (HRPEpiC) were purchased from ScienCell Research
Laboratories (Carlsbad, CA, USA). Other chemicals were ordered from
Sigma (St. Louis, MO, USA), unless otherwise indicated.

HRPEpiC culture and experimental design
HRPEpiC were grown in complete media and divided in to 4 groups
(control, NACA, TBHP and NACA+TBHP). Cells were pretreated with
2 mM NACA (in NACA and NACA+TBHP groups) or serum-free media (in control and TBHP groups). After 4 h incubation, the media was
removed, and followed by dosing with 0.5 mM TBHP for 3 h. For apoptosis assays, an alternative NACA and TBHP dosing protocol was used
in addition to the one described above. This involved pretreatment with
NACA for 1 h prior to TBHP exposure and addition of NACA for another 3 h (i.e., the NACA+TBHP group cells were co-exposed to TBHP
and NACA for 3 h).

Cell viability assay
1×105 cells per well were seeded in a 96-well plate for 24 h before further dosing. After cells were treated as indicated in the experimental design, 2 μM Calcein-AM (Biotium Inc., CA) was added to each well, and
cells were incubated for 30 min before measuring the fluorescence by
plate reader (λex = 485 nm and λem = 530 nm) (FLUOstar Omega, BMG
Labtech).

Intracellular ROS measurement
10 μM of CM-H2DCFDA (Molecular Probes, Life Technologies) was
loaded prior to dosing according to the experimental design. Fluorescence was measured after treatment (λex = 485 nm and λem = 530 nm).

Quantification of intracellular glutathione (GSH) levels
Cells were grown at a density of 1.2×106 per 10-cm plate for 24 h before further treatment. GSH was separated and quantified by HPLC with
fluorescence detection (Finnigan Surveyor FL Plus, Thermo Scientific)
after derivatization of cell homogenates with N-(1-pyrenyl)maleimide
(NPM).16

Glutathione reductase (GR) activity assay
Cells were homogenized in 250 μl of 50 mM Tris-HCl (pH = 7.5) containing 1 mM EDTA. NADPH, which absorbs light at 340 nm, was added
to each sample. The rate of its oxidation to NADP+ by GR as GSSG is
reduced to 2 GSH can be determined from the resulting decrease in absorbance at this wavelength over time.17
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Determination of Protein
Protein levels of the cell homogenates were measured by the Bradford
method (BioRad Laboratories, Inc., CA, USA). Bovine serum albumin
was used as the protein standard.

Dextran permeability and transepithelial electrical
resistance (TEER) measurement
12-mm Transwell inserts were coated with poly-L-lysine for 1 h prior
to seeding 0.5 ml at 1×106 cells/ml. Cell growth was maintained for 5
days without disturbing the monolayer. Fluorescently labelled dextrans
(FD4, 1 mg/ml) were administered apically onto the insert after dosing.
Fluorescence was read after 30 min (λex =485 nm and λem = 530 nm). The
inserts containing the monolayer were then transferred to a new well
with serum-free phenol red-free media and used for TEER measurement
with an EVOM voltohmmeter (World Precision Instrument, Sarasota,
FL, USA) to assess the integrity of HRPEpiC monolayer.

Flow cytometry quantification of apoptotic cells
Cells were grown in 6-cm plates and dosed as described by the experiment design. Trypsinized cells were re-suspended in binding buffer
containing 7-AAD and annexin V-FITC (BD Biosciences, San Jose, CA,
USA). Cells were incubated for 15 minutes at room temperature in the
dark then analyzed by Cell Lab Quanta SC flow cytometry (Beckman
Coulter, Fullerton, CA, USA).

Statistical Analysis
All values are reported as mean ± SD (n = 3-10). Statistical analysis was
performed using GraphPad Prism 5 software (GraphPad, San Diego,
CA, USA). Statistical significance was performed by one-way analysis
of variance (ANOVA), followed by Tukey’s multiple comparison tests.
#, ## and ### represent P<0.05, 0.01 and 0.001, respectively, compared
to control; *, ** and *** represent P<0.05, 0.01 and 0.001, respectively,
compared to TBHP group.

RESULTS
TBHP increased intracellular ROS levels in HRPEpiC, and
NACA prevented ROS generation
To investigate ROS generation in response to TBHP treatment, ROS levels were measured after exposing cells to TBHP for 3 h. TBHP induced
ROS generation in a dose-dependent manner (Figure 1A). ROS levels in
TBHP-treated cells were 177% of those observed in the control group
(P<0.001). Pretreatment with NACA decreased ROS levels to 126% of
those observed in the control group (P<0.001 compared to TBHP group)
(Figure 1B).

Dose-dependent GSH depletion by TBHP and revention
by pretreatment with NACA
To elucidate the consequences of elevated ROS in HRPEpiC, GSH levels
were measured after treatment for 3 h with various concentrations of
TBHP. TBHP decreased cellular GSH levels in a dose-dependent manner: the average GSH levels in cells treated with 0, 0.5, 1, 25 and 50 mM
TBHP were 33.4 ± 5.0, 25.1 ± 1.5, 18.9 ± 0.7, 8.8 ± 1.9 and 6.2 ± 1.3 nmol/
mg protein, respectively (P<0.001 compared to control) (Figure 2A). The
protective effect of NACA on GSH depletion in cells treated with TBHP
was also investigated (Figure 2B). GSH is the major antioxidant in the
cell and NACA is a GSH precursor, providing cysteine for GSH synthesis. The average GSH level in the control group was 31.7 ± 2.3 nmol/mg
protein. The GSH level was increased after NACA incubation (55.1 ± 7.3
nmol/mg protein, P<0.001 compared to control). The average GSH level
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of the TBHP group was 25.1 ± 1.5 nmol/mg protein (P<0.01 compared
to control), but the NACA+TBHP group had an average GSH level of
30.5 ± 2.5 nmol/mg protein (P < 0.05, compared to the TBHP group).

Preservation of glutathione reductase activity by
pretreatment with NACA
Glutathione reductase (GR), an enzyme which reduces glutathione disulfide to GSH, is important in restoring intracellular levels of GSH. GR
activity was reduced in the TBHP group (33.5 ± 3.2 versus 21.9 ± 2.2
mU/mg protein in the control group; P<0.01) (Figure 3). NACA-pretreated cells exhibited increased GR activity (33.5 ± 5.2 mU/mg protein;
P<0.01 compared to the TBHP group).

Effects of oxidative stress on HRPEpiC monolayer
paracellular permeability and contribution of NACA to
monolayer functional homeostasis
RPE paracellular permeability was assessed in HRPEpiC grown on
a polycarbonate insert, which form a monolayer similar to that of the
blood-retina barrier in vivo. Transepithelial electrical resistance (TEER)
was used as a measure of paracellular permeability to ions, where lower
electrical resistance is evidence of decreased membrane integrity of HRPEpiC in the monolayer. Permeability to non-ionic molecules was determined based on the amount of dextran able to pass through the monolayer within 30 min. Compared to the TBHP group, the NACA+TBHP
group exhibited significantly greater electrical resistance (Figure 4A).
Dextran permeability in the TBHP group was significantly higher than
control (P<0.05) (Figure 4B).

Figure 1: Intercellular ROS levels were measured using DCF fluorescence.
(A) TBHP induced ROS generation in a dose-dependent manner. (B) NACA
prevented TBHP-induced ROS generation.

Figure 2: Intracellular GSH levels in HRPEpiC. (A) TBHP depleted GSH levels
in a dose-dependent manner. (B) NACA dramatically increased intracellular
GSH levels and prevented GSH depletion by TBHP.

Cell viability and lethal effects of TBHP in HRPEpiC
To investigate cell survival in response to ROS generation, cell viability assays were performed after treatment (Figure 5). Pretreatment with
NACA alone did not affect cell viability (91.1 ± 4.5%) compared to control (100.0 ± 10.1%). Cell viability was reduced in the TBHP group (52.2
± 5.5%, P<0.001). Pretreatment with NACA provided slight but not statistically significant protection against TBHP-induced cell death.

Annexin V-FITC and 7-aminoactinomycin-D (7-AAD)
detection of apoptosis by flow cytometry
NACA has multiple antioxidant properties. It is a well-known GSH prodrug and a free radical scavenger.18-20 In cell-free systems, NACA can
non-enzymatically restore GSH through thiol-disulfide exchange with
the oxidized form, GSSG.21 An annexin V-FITC and 7-AAD double
staining assay was performed. Cells in the early apoptotic stages only
bind annexin V-FITC, while cells in late apoptotic stages bind both annexin-V-FITC and 7-AAD. Dead/necrotic cells may only exhibit 7-AAD
fluorescence, due to membrane disintegration and subsequent loss of
phosphatidylserine. Table 1 summarizes the percent distribution of viable cells and cells in the early and late stages of apoptosis. The percentages of viable cells in the TBHP and NACA+TBHP groups are very similar (64.0 ± 4.9 % versus 67.8 ± 9.9 %). There was no significant difference
in the number of dying cells (defined as the total of early- and late-stage
apoptotic cells) between the TBHP and the NACA+TBHP groups (20.5
± 6.1% versus 20.8 ± 4.8%). Because no significant improvement was
observed in the cells pretreated with NACA, the dosing protocol was
modified slightly without changing the total NACA exposure time (see
Methods). Results of the modified treatment protocol are shown in Figure 6 and Table 2. In the NACA+TBHP (co-exposed) group, the percentage of viable cells (88.6 ± 0.1%) was significantly higher than that in the
TBHP group (48.5 ± 5.1%, P<0.001). The percentages of dying cells in
the TBHP group and the NACA+TBHP co-exposure group were 16.5 ±
3.6% and 5.5 ± 0.8%, respectively.
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Figure 3: Preservation of glutathione reductase activity by NACA.
Table 1: Percent distribution of viable cells and cells in the early and
late stages of apoptosis after 4 h pretreatment with NACA followed by
3 h TBHP exposure.
Groups

Control

2 mM
NACA

0.5 mM
TBHP

NACA+TBHP

Viable cells

94.8 ± 1.3

93.7 ± 0.5

64.0 ± 4.9

67.8 ± 9.9

Early
apoptotic cells

1.3 ± 0.6

3.0 ± 1.1

1.8 ± 0.8

2.1 ± 0.4

Late apoptotic
cells

1.9 ± 0.2

2.1 ± 0.5

18.8 ± 5.4

18.6 ± 4.9

The results are shown as mean % of total cells ± SD.
Free Radicals and Antioxidants, Vol 7, Issue 2 Jul-Dec, 2017

Wang et al: NACA defends against oxidative stress in RPE.

Figure 4: Protective effects of NACA on paracellular permeability in HRPEpiC. (A) Results of TEER measurement. (B) Results of dextran permeability
assays.

Figure 6: Flow cytometry analysis of apoptotic cells following the modified (co-exposure) protocol with NACA and TBHP. The dot plots show twoparameter analysis of fluorescence intensity of annexin-V FITC (FL1) and
7-AAD (FL3).

Figure 5: Effects of NACA and TBHP on HRPEpi cell viability.
Table 2: Percent distribution of viable cells and cells in the early and
late stages of apoptosis from Figure 6.
Groups

Control

2 mM
NACA

0.5 mM
TBHP

NACA+TBHP

Viable cells

90.4 ± 1.2

84.8 ± 4.2

48.5 ± 5.1a

88.6 ± 0.0b

Early apoptotic
cells

2.2 ± 0.3

1.7 ± 0.9

2.2 ± 1.0

2.3 ± 0.3

Late apoptotic
cells

2.5 ± 0.4

4.4 ± 0.2

14.3 ± 3.5

3.1 ± 0.5

The results are shown as mean % of total cells ± SD. (a, P < 0.001 compared to
control group; b, P < 0.001 compared to TBHP group).

DISCUSSION
In this study, we evaluated the potential of NACA to prevent oxidative
stress-related damage in vitro in HRPEpiC. This allowed for evaluation
of NACA as a defense against TBHP-induced oxidative injury. Selection
of the best in vitro analogue to RPE in AMD patients was vital to the
clinical relevance of our results. Currently, there are three cell models
used to study the effects of oxidative stress on the RPE: ARPE-19, fetal
human RPE cells (fhRPE) and primary culture adult human RPE (e.g.,
HRPEpiC). ARPE-19 is a spontaneously arising retinal pigment epithelial cell line derived from normal eyes. The fhRPE and HRPEpiC are primary cultures of fetal and adult human RPE cells, respectively. When
Free Radicals and Antioxidants, Vol 7, Issue 2, Jul-Dec, 2017

compared to ARPE-19, fhRPE cells are healthier; however, adult human
RPE are more physiologically representative of the mature function of
RPE than fhRPE.22,23 Thus, an adult human primary RPE cell model was
implemented for the experiments detailed here.
The RPE of the macula is particularly vulnerable to oxidative damage
due to increased O2 exposure, photo-oxidation, elevated metabolic activity, and high proportion of polyunsaturated fatty acids.5 Our data demonstrates that TBHP increased ROS levels in a dose-dependent manner, leading to severe oxidative stress in the HRPEpiC cultures. NACA
pre-incubation prevented TBHP-induced ROS production in HRPEpiC.
It has been shown that accumulation of ROS induces severe oxidative
stress in RPE cells, which is manifested by significant reduction in levels
of GSH (the most critical antioxidant and redox buffer of the cell).24,25
Results from our study showed a significant decrease in GSH levels in
the HRPEpiC when compared to those of the control group (Figure 2).
Pretreatment with NACA significantly increased GSH levels. This may
indicate that NACA replenished GSH levels, leading to reversal of oxidative stress. The protective effects of NACA are probably mediated by a
number of pathways, which may include supplying cysteine for GSH biosynthesis, reduction of extracellular cystine to cysteine, and conversion
of GSSG to GSH by the action of GR and by non-enzymatic thiol disulfide exchange.12,26-28 Our results are in agreement with previous studies
which reported an increase in GSH levels after NACA incubation and a
decrease in GSH levels upon TBHP treatment in an ARPE cell line.11,14
Importantly, changes in the GR activity were also observed. GR regenerates GSH from GSSG and plays an important role in GSH homeostasis.29
NACA treatment increased the levels of GSH and restored GR activity
(Figure 3). Our results are in line with another study that reported inhibition of GR activity in HepG2 upon TBHP treatment.30
In the retina, the RPE forms the blood-retinal barrier (BRB) with tight
junctions that control the exchange of nutrients and metabolites between
the retina and the underlying choriocapillaris. It is thought that oxida175
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tive stress may induce changes in the BRB, which may contribute to the
pathogenesis of retinal degeneration. To investigate the ability of NACA
to preserve BRB function, membrane integrity after TBHP exposure was
evaluated using dextran permeability and TEER assays.31 NACA prevented TBHP-induced reduction in TEER, verifying its ability to protect cellular homeostasis and outer BRB integrity under severe oxidative stress conditions. A similar decrease in TEER has been reported in
another study, where human embryonic stem cell (hESC)-derived RPE
cells and ARPE-19 cells were exposed to hydrogen peroxide.31,32 These results are also in agreement with a previous study performed in our laboratory using the ARPE-19.14 However, we did not observe any significant
difference in dextran permeability upon NACA treatment, which could
be due to lower sensitivity of dextran permeability when compared with
TEER.33
The decline in GSH observed creates a redox imbalance that enhances
cell susceptibility to injury and ROS-induced apoptosis. Altering the redox state to a more reduced environment by addition of GSH has been
shown to decrease sensitivity of RPE cells to apoptosis from ROS.34,35
We initially investigated the protective effect of NACA pretreatment by
studying cell viability. However, no significant improvement was noted
in cell survival using either the Calcein-AM assay or flow cytometry.
We therefore modified our study design to include co-exposure along
with pre-incubation and dramatically improved cell survival (Figure 6).
It is possible that pretreatment alone is not sufficient to address multiple oxidative stress-related apoptotic mechanisms. Oxidants, such as
TBHP, may induce apoptosis through two different pathways: (1) Fas-Fas
ligand activation and (2) mitochondrial damage and subsequent release
of cytochrome c.36 Because the interplay of these two pathways is complex, it is plausible that antioxidant treatments, while producing a more
favorable redox status in the cell, may not fully address both apoptotic
pathways. In addition, concentrations of TBHP (0.5 mM) and NACA (2
mM) chosen for our investigation may be too high and low, respectively,
to observe significant cytoprotection by pretreatment with NACA. Our
previous studies with ARPE-19 indicate that up to 10 mM NACA may be
used to beneficial effect as a pretreatment for 0.4 mM TBHP exposure.14

CONCLUSION
This study demonstrates that treatment of retinal pigment epithelium
with NACA protected against oxidative stress-induced cellular injury.
NACA also inhibited oxidative stress-related breakdown of the bloodretinal barrier as measured by TEER. The proposed mechanism of action involves NACA scavenging existing ROS and increasing levels of
reduced glutathione. With the prevalence of AMD and other retinal
degeneration disorders expected to double in the coming decades, the
development of more effective therapies to prevent its progression is imperative. Our results indicate that NACA has the potential to become
an effective therapeutic agent by enhancing antioxidant defenses while
removing pathologically relevant ROS.
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ABBREVIATION USED
AMD: Age-related macular degeneration; 7-AAD: 7-aminoactinomycin-D; AREDs: Age-related eye diseases; GPx: Glutathione peroxidase;
GR: Glutathione reductase; GSH: Glutathione; GSSG: Reduces glutathione disulfide; HRPEpiC: Primary human retinal pigment epithelial cells;
NACA: N-acetylcysteine amide; NPM: N-(1-pyrenyl)-maleimide; ROS:
reactive oxygen species; RPE: Retinal pigment epithelium; TBHP: Tertbutyl hydroperoxide; TEER: Transepithelial electrical resistance.
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SUMMARY
• TBHP increased intracellular ROS levels in HRPEpiC, and NACA prevented ROS generation.
• Dose-dependent GSH depletion by TBHP was prevented by pretreatment
with NACA.
• Pretreatment with NACA preserved of GR activity.
• NACA inhibited oxidative stress-related breakdown of HRPEpiC monolayer paracellular permeability.
• NACA significantly improved cell survival when administered prior to and
during oxidative damage.
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